Antibody–drug conjugates treatment of small cell lung cancer: advances in clinical research
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Antibody–drug conjugates treatment of small cell lung cancer: advances in clinical research ; volume:15 ; number:1 ; day:1 ; month:8 ; year:2024 ; pages:1-11 ; date:12.2024
Discover oncology ; 15, Heft 1 (1.8.2024), 1-11, 12.2024
- Creator
-
Meng, Yuan
Wang, Xuerui
Yang, Jie
Zhu, Meiying
Yu, Minghui
Li, Longhui
Liang, Yangyueying
Kong, Fanming
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-01171-1
- URN
-
urn:nbn:de:101:1-2410250907339.762078529703
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meng, Yuan
- Wang, Xuerui
- Yang, Jie
- Zhu, Meiying
- Yu, Minghui
- Li, Longhui
- Liang, Yangyueying
- Kong, Fanming
- SpringerLink (Online service)
Other Objects (12)
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Investigating processes and impacts of climate change on seawater intrusion in a coastal aquifer
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Antibody–drug conjugates as an emerging therapy in oncodermatology
Antibody–drug conjugates in the treatment of lymphoid neoplasms
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Investigating processes and impacts of climate change on seawater intrusion in a coastal aquifer
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Antibody–drug conjugates as an emerging therapy in oncodermatology
Antibody–drug conjugates in the treatment of lymphoid neoplasms
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Investigating processes and impacts of climate change on seawater intrusion in a coastal aquifer
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Antibody–drug conjugates as an emerging therapy in oncodermatology